# Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.

> **NCT04610229** · NA · COMPLETED · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 12 (actual)

## Conditions studied

- Glioblastoma Multiforme
- Glioblastoma
- Glioblastoma, Adult

## Interventions

- **RADIATION:** Hypofractionation guioded by dose painting

## Key facts

- **NCT ID:** NCT04610229
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-01
- **Primary completion:** 2019-08-12
- **Final completion:** 2019-08-26
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04610229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04610229, "Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04610229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*